熱點掃描 | 醫美概念股部分上漲，復銳醫療科技漲5.6%
uSMART盈立智投7月27日消息，截止發稿，港股三大指數齊跌，恆生指數跌1.34%，報20626.89點，成交額322.72億；國企指數跌1.49%，報7075.15點，成交額93.62億；紅籌指數跌1.19%，報3705.57點，成交額9.04億。
內房股下挫，旭輝控股集團跌超9%，龍湖地產跌5%，合景泰富集團、富力地產跌超4%；
內地物管股走弱，旭輝永升服務、金科服務跌超5%，時代鄰裏跌超3%，世茂服務跌超2%；
醫療保健板塊走弱，諾輝健康、百心安跌超3%，微創醫療跌超2%；
菸草概念板塊下挫，華寶國際跌超10%，思摩爾國際、中煙香港跌超1%；
新能源汽車股走低，理想汽車跌超5%，蔚來汽車跌超3%，小鵬汽車跌近3%，長城汽車、吉利汽車跌超2%；
醫美概念股部分上漲，復銳醫療科技漲5.6%，時代天使漲超2%，四環醫藥、昊海生物科技均有漲幅，中信證券分析師認爲，醫美行業處於發展初期，滲透率有較大提升空間，且隨着監管加強，合規市場將對不合規市場形成加速替代。
熱門股
騰盛博藥-B漲超4%，報9.93港元，總市值71.77億港元，騰盛博藥-B公佈，新的活病毒數據確認其長效新冠單克隆中和抗體安巴韋單抗和羅米司韋單抗聯合療法對新冠病毒奧密克戎(Omicron)BA.4/5及BA.2.12.1亞型變異株保持中和活性，目前美國食品和藥品管理局正在對安巴韋單抗和羅米司韋單抗聯合療法的緊急使用授權申請進行審覈；
五礦資源跌7.17%，報2.46港元，總市值212.5億港元，該公司日前公佈，2022年第二季度，銅總產量爲44,514噸，較第一季度減少52%，產量減少乃由於Las Bambas社區抗議活動，導致礦山停產逾50天，鑑於長時間停產及對話結果不確性帶來的影響，集團撤銷Las Bambas 2022年的生產指導。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app！
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
